Abstract
Toll-like receptor (TLR) ligands that signal via TIR-domain-containing adapter-inducing IFN beta (TRIF) activate the I kappa B kinase (IKK)-related kinases, TRAF associated NF kappa B activator (TANK)-binding kinase-1 (TBK1) and IKK epsilon, which then phosphorylate IRF3 and induce the production of IFN beta. Here we show that TBK1 and IKK epsilon are also activated by TLR ligands that signal via MyD88. Notably, the activation of IKK epsilon is rapid, transient, and it precedes a more prolonged activation of TBK1. The MyD88- and TRIF-dependent signaling pathways activate the IKK-related kinases by two signaling pathways. One is mediated by the canonical IKKs, whereas the other culminates in the autoactivation of the IKK-related kinases. Once activated, TBK1/IKK epsilon then phosphorylate and inhibit the canonical IKKs. The negative regulation of the canonical IKKs by the IKK-related kinases occurs in both the TRIF- and MyD88-dependent TLR pathways, whereas IRF3 phosphorylation is restricted to the TRIF-dependent signaling pathway. We have discovered that the activation of IKK epsilon is abolished, the activation of TBK1 is reduced, and the interaction between the IKK-related kinases and the canonical IKKs is suppressed in TANK(-/-) macrophages, preventing the IKK-related kinases from negatively regulating the canonical IKKs. In contrast, IRF3 phosphorylation and IFN beta production was normal in TANK(-/-) macrophages. Our results demonstrate a key role for TANK in enabling the canonical IKKs and the IKK-related kinases to regulate each other, which is required to limit the strength of TLR signaling and ultimately, prevent autoimmunity.
Original language | English |
---|---|
Pages (from-to) | 17093-17098 |
Number of pages | 6 |
Journal | Proceedings of the National Academy of Sciences of the United States of America |
Volume | 108 |
Issue number | 41 |
DOIs | |
Publication status | Published - 11 Oct 2011 |
Keywords
- IKK-EPSILON
- POLYUBIQUITIN BINDING
- ANTIVIRAL RESPONSE
- NF-KAPPA-B1 P105
- VIRAL-INFECTION
- INNATE IMMUNITY
- ACTIVATION
- TBK1
- LIPOPOLYSACCHARIDE
- PATHWAY